Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Ebola: Sierra Leone Officials Criticize Travel Relaxation

By Drug Discovery Trends Editor | February 3, 2015

Although Ebola cases are declining in West Africa, Sierra Leone officials are worried that the president’s decision to lift travel restrictions may re-ignite the spread of the deadly disease.

President Ernest Bai Koroma two weeks ago announced a relaxation of travel restrictions to support economic activity. Some officials agreed that the closure of roads hurt the economy. Others felt it was too soon.

“It was slightly too early,” Freetown Mayor Franklyn Bode Gibson said Tuesday. “We do not know who is safe and who is not,” and a second outbreak of the disease would be distrastrous.

Gibson said Tuesday he will call for a meeting this week with the National Ebola Response Center to register his disappointment about the re-opening of district roads.

The chairman of the eastern Kenema District, Dr. Senesie Mansaray, said the move to lift travel restrictions is “a serious blunder at this point in time.” He said that Bai Koroma should have waited until the end of February or March, while observing the trend of the spread of the virus, to put more mechanisms in place before lifting bans. The Kenema district recorded no new cases in the latest government figures.

The three most affected countries – Guinea, Sierra Leone and Liberia – appear to be making strides against the Ebola epidemic first identified last March. The U.N. health agency said last week that the countries had reported fewer than 100 cases in the past week, for the first time since June. Nearly 9,000 people have died from the virus spread through contact with bodily fluids.

Fears are “legitimate” according to opposition party publicity secretary Tamba Samba, but he added that the closure of the roads had hurt the economy.

Ibrahim Bundu, the leader of the governing All People’s Congress, said on a radio discussion that the decision to lift the travel ban was made to “boost the country’s Ebola defunct economy.”

Koroma has set a goal of zero cases by the end of March.

Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50